Medical News

RSS

Health overhaul mandates spur lobbying push for waivers, Bloomberg reports

The new health law has created an open-season atmosphere for Washington lobbyists seeking waivers and other changes.

21 Jan 2011

NIMH awards Case Western Reserve $7.8M renewal grant to study manic symptoms in children

The Department of Psychiatry at Case Western Reserve University School of Medicine has received a $7.8 million renewal grant from the National Institute of Mental Health (NIMH) for the long-term study of manic symptoms in children.

21 Jan 2011

GOP anti-abortion bill introduced in House

This divisive issue promises to stir up politics on the Hill and trigger debates about federal funding that will include issues related to the health law.

21 Jan 2011

After repeal vote, what becomes of health reform messaging, public opinions

News outlets report on how the next chapters of the debate will be marked by both parties seeking to "mold" public opinion. An example: a recent speech by Newt Gingrich in which he warns of a possible "health dictatorship." In the background, polls continue to explore how the American public views the law.

21 Jan 2011

Pharmasset prices underwritten public offering of 3,300,000 shares of common stock

Pharmasset, Inc. announced today the pricing of an underwritten public offering of 3,300,000 shares of its common stock at an offering price of $46.33 per share. Of the shares being sold, Pharmasset is selling 2,300,000 shares and the selling stockholders are selling 1,000,000 shares. Pharmasset expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $101.5 million.

21 Jan 2011

Viewpoints: Disputing the costs -- or savings -- of the health law; Britain's NHS; 'Fixing' Wis. Medicaid

With this week's vote to repeal President Obama's health care reform, House Republicans struck a blow for freedom. They struck a blow for the freedom of hospitals to avoid financial penalties, no matter how many Medicare patients develop infections under their care. They struck a blow for the freedom of hospitals to avoid consequences, no matter how many Medicare patients are readmitted soon after treatment.

21 Jan 2011

Roundup: NY Times on mental health cuts; Wis. GOP agenda moves ahead; Minn. Medicaid expansion

Gov. Mark Dayton said during his campaign that enrolling 95,000 people in an expanded Medicaid program would be his top priority when he took office -- and he meant it. Less than three weeks after he was told by members of former Gov. Tim Pawlenty's administration that it could take until October to enact the change, Dayton announced Thursday that it would be done by March 1.

21 Jan 2011

Novel FAK inhibitors targeting binding site of VEGFR-3 reduce growth of pancreatic cancer cells

CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented research results at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) reduced the growth of pancreatic cancer cells in vitro and in vivo.

21 Jan 2011

Everist Genomics reports positive results from OncoDefender-CRC assay external validation study

Everist Genomics, a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence, today announced the positive results of the first external validation study of its OncoDefender-CRC colorectal cancer recurrence test. The study is being conducted by Mayo Validation Support Services, and is being coordinated with investigators and resources from all three Mayo Clinic sites.

21 Jan 2011

Researchers reveal how genetic mutation contributes to cancer development

Scientists around the world have been hot on the trail of a genetic mutation closely associated with some brain cancers and leukemia since the mutation's discovery in 2008. The hunt is now yielding fruit. In the Jan. 18, 2011 issue of Cancer Cell, researchers reveal how the mutation contributes to cancer development and suggest potential ways to counter its effects.

21 Jan 2011

Perceived threat, rather than actual events, predict brain adaptation

A study of soldiers who took part in the ISAF mission in Afghanistan between 2008 and 2010 has found that their brains adapt when they are continuously exposed to stress. The perceived threat appears to be the major predictor of brain adaptation, rather than the actual events. In other words, if a roadside bomb goes off right in front of you, the degree to which you perceive this as threatening is what counts. This is what determines how the brain and the stress system adapt.

21 Jan 2011

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

During an investor meeting held today in New York, NY, Watson Pharmaceuticals, Inc. provided an update on its Global businesses, including a detailed overview of its commercial operations and pipeline developments within its Global Generics and Global Brands businesses, and an update of achievements within its Global Operations. In conjunction with the meeting, the Company provided its preliminary 2011 financial and long term growth forecasts.

21 Jan 2011

Cancer Research UK launches new Centre in Glasgow

Cancer Research UK today (Thursday) launches a new Centre which will accelerate the pace of research in Glasgow and see the city become a world leader in the development of new treatments tailored for individual cancer patients.

21 Jan 2011

NYC Council Member introduces legislation to prohibit fluoridation of water supply

On January 18, 2011, NYC Council Member Peter Vallone, Jr. introduced legislation (Int 0463-2011) "prohibiting the addition of fluoride to the water supply

21 Jan 2011

Jiangbo Pharmaceuticals reaches settlement with debenture holders

Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced that it has reached a settlement with the holder of its November 2007 Debenture and with the holders of its May 2008 Notes under which the Company has agreed to issue to such holders a total of 886,277 shares of its common stock as a payment for all delinquent interest and associated penalties with respect to its November 2007 Debenture and May 2008 Notes.

21 Jan 2011

Additional data from HyperAcute Pancreas cancer immunotherapy Phase 2 trial to be presented at ASCO 2011

NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the company's investigational HyperAcute® Pancreas cancer immunotherapy will be presented during a poster session at the American Society of Clinical Oncology 2011 Gastrointestinal Cancers Symposium in San Francisco, California.

21 Jan 2011

PenTAG research plays pivotal role in NICE decision to extend availability of Alzheimer's disease drugs

A review of research evidence produced by researchers from the Peninsula Technology Assessment Group, part of the Peninsula College of Medicine and Dentistry, has played a pivotal role in the decision by the National Institute for Health and Clinical Excellence (NICE) to extend the availability of donepezil, galantamine, rivastigmine and memantine for Alzheimer's disease announced on 18th January 2011.

21 Jan 2011

SQI fourth quarter net loss increases to $2,621,000

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced its financial and operational results for the fourth quarter and year ended September 30, 2010.

21 Jan 2011

Acetylation complex fits like a halo over a histone

To understand the emerging science of epigenetics-a field that describes how genes may be regulated without altering the underlying DNA itself-scientists are deciphering the many ways in which enzymes act on the proteins surrounding DNA within cells.

21 Jan 2011

Intellipharmaceutics receives purchase agreement commitments for $12,000,000

Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.

21 Jan 2011

Medical News

Health overhaul mandates spur lobbying push for waivers, Bloomberg reports

NIMH awards Case Western Reserve $7.8M renewal grant to study manic symptoms in children

GOP anti-abortion bill introduced in House

After repeal vote, what becomes of health reform messaging, public opinions

Pharmasset prices underwritten public offering of 3,300,000 shares of common stock

Viewpoints: Disputing the costs -- or savings -- of the health law; Britain's NHS; 'Fixing' Wis. Medicaid

Roundup: NY Times on mental health cuts; Wis. GOP agenda moves ahead; Minn. Medicaid expansion

Novel FAK inhibitors targeting binding site of VEGFR-3 reduce growth of pancreatic cancer cells

Everist Genomics reports positive results from OncoDefender-CRC assay external validation study

Researchers reveal how genetic mutation contributes to cancer development

Perceived threat, rather than actual events, predict brain adaptation

Watson predicts $4.2 billion in revenues from Global Generics and Global Brand businesses

Cancer Research UK launches new Centre in Glasgow

NYC Council Member introduces legislation to prohibit fluoridation of water supply

Jiangbo Pharmaceuticals reaches settlement with debenture holders

Additional data from HyperAcute Pancreas cancer immunotherapy Phase 2 trial to be presented at ASCO 2011

PenTAG research plays pivotal role in NICE decision to extend availability of Alzheimer's disease drugs

SQI fourth quarter net loss increases to $2,621,000

Acetylation complex fits like a halo over a histone

Intellipharmaceutics receives purchase agreement commitments for $12,000,000

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News